Trial intelligence / Profile preview

Nociceptive and antinociceptive mechanisms under anesthesia using fMRI, EEG and noxious reflexes

DRKS00000663Phase 4Completed

Sponsor
Charité – Universitätsmedizin Berlin
Start
Dec 2012
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of propofol and remifentanil, sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Nociceptive and antinociceptive responses under anesthesia. Started Dec 2012; status: completed.

02

Drugs

propofolremifentanil

Beyond the preview

Go deeper on DRKS00000663.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00000663.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call